Arrowhead Pharmaceuticals Net Income vs. Return On Asset
| 0HI3 Stock | 26.30 4.45 20.37% |
Net Loss | First Reported 1998-03-31 | Previous Quarter -125.3 M | Current Value -170.8 M | Quarterly Volatility 31.7 M |
For Arrowhead Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Arrowhead Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Arrowhead Pharmaceuticals Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Arrowhead Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Arrowhead Pharmaceuticals Corp over time as well as its relative position and ranking within its peers.
Arrowhead |
Arrowhead Pharmaceuticals Return On Asset vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Arrowhead Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Arrowhead Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Arrowhead Pharmaceuticals Corp is rated fourth in net income category among its peers. It also is rated fourth in return on asset category among its peers . At this time, Arrowhead Pharmaceuticals' Net Loss is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arrowhead Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Arrowhead Return On Asset vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Arrowhead Pharmaceuticals |
| = | (209.28 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Arrowhead Pharmaceuticals |
| = | -0.41 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Arrowhead Return On Asset Comparison
Arrowhead Pharmaceuticals is currently under evaluation in return on asset category among its peers.
Arrowhead Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Arrowhead Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Arrowhead Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Arrowhead Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Arrowhead Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -2.9 M | -2.8 M | |
| Operating Income | -184.5 M | -175.3 M | |
| Income Before Tax | -185.8 M | -176.5 M | |
| Total Other Income Expense Net | -1.7 M | -1.6 M | |
| Net Loss | -188.3 M | -178.9 M | |
| Income Tax Expense | 3.2 M | 3.4 M | |
| Interest Income | 7 M | 5.5 M | |
| Net Loss | -184.7 M | -175.5 M | |
| Change To Netincome | 104 M | 57.5 M |
Arrowhead Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Arrowhead Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Arrowhead Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Arrowhead Pharmaceuticals' important profitability drivers and their relationship over time.
Use Arrowhead Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arrowhead Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Arrowhead Pharmaceuticals Pair Trading
Arrowhead Pharmaceuticals Corp Pair Trading Analysis
The ability to find closely correlated positions to Arrowhead Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arrowhead Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arrowhead Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arrowhead Pharmaceuticals Corp to buy it.
The correlation of Arrowhead Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arrowhead Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arrowhead Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arrowhead Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Arrowhead Pharmaceuticals position
In addition to having Arrowhead Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tips ETFs Thematic Idea Now
Tips ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Tips ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tips ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.